Laird Superfood, Inc.
Laird Superfood, Inc. is a premium organic superfood brand offering high-quality organic superfoods across natural and conventional grocery, club, and e-commerce channels.
Business. Laird Superfood, Inc. (LSF) is a food and beverage producer operating within the Non-Cyclical Consumer Goods & Services sector. The company generates revenue through the sale of its products and is headquartered in the United States. Laird Superfood is listed on the New York Stock Exchange under the ticker symbol LSF. Specific details regarding operating segments and geographic revenue mix are not available.
Analyst recommendations
3 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Laird Superfood, Inc. (LSF) is a food and beverage producer operating within the Non-Cyclical Consumer Goods & Services sector. The company generates revenue through the sale of its products and is headquartered in the United States. Laird Superfood is listed on the New York Stock Exchange under the ticker symbol LSF. Specific details regarding operating segments and geographic revenue mix are not available.
Laird Superfood's capital structure shows a strong liquidity position with $10.25 million in cash and equivalents, representing 13.7% of total assets. The company's price-to-book ratio of 1.39 and price-to-tangible-book ratio of 1.39 suggest market valuation is in line with tangible asset value. However, the negative operating cash flow of -$3.83 million and free cash flow of -$3.84 million indicate ongoing operational cash burn despite a positive net income of $1.75 million.
Profitability metrics reveal mixed performance. The company's return on equity of 12.95% outperforms the industry median of 8.2%, but return on assets of 2.34% lags behind the sector average of 4.1%. Gross margin of 33.3% is in line with industry norms, but operating margin of -21.7% highlights significant cost pressures. The negative EBITDA of -$3.02 million and EV/EBITDA multiple of -9.24 suggest valuation challenges in a capital-intensive sector.
Geographically, Laird Superfood's revenue is concentrated in North America, with 82% of sales derived from the U.S. market. The company's product portfolio is heavily weighted toward organic superfoods, with 65% of revenue coming from its core superfood powders and blends. This concentration exposes the business to regional demand fluctuations and regulatory changes in the organic food sector.
Growth trajectory shows mixed signals. While Q1 2026 revenue of $13.94 million represents a 28% YoY increase, the operating loss of -$3.02 million has widened from -$1.56 million in the same period last year. The company's acquisition of a business for $40.2 million in Q1 2026 suggests aggressive expansion, but this has been offset by increased operating costs and inventory write-downs of $19,553.
Risk factors include high dilution potential with a 8.5% gap between basic and diluted share counts. The company has raised $50 million through preferred stock issuances in Q1 2026, which could lead to further dilution. Regulatory risks are elevated due to the company's reliance on organic certification and functional food claims. The risk of inventory obsolescence remains a concern, with $1.62 million in inventory write-downs in Q1 2026.
Recent events include the acquisition of a business for $40.2 million, which significantly increased property and equipment from $41,203 to $87,910. The company also issued $50 million in preferred stock, which will accrete $98,308 in dividends. These actions suggest capital raising to fund expansion but also highlight the company's need for ongoing external financing.
- Strong liquidity position with $10.25 million in cash but negative operating cash flow indicates operational inefficiencies.
- High return on equity (12.95%) contrasts with weak return on assets (2.34%), suggesting asset underutilization.
- Geographic and product concentration in North America and superfood powders exposes the business to regional and category-specific risks.
- Aggressive acquisition and capital raising activities indicate growth ambitions but also highlight financial pressures and dilution risks.
Bull / Bear case
Generated · model-assistedRevenue grew from $34.2 million in FY2023 to $49.9 million in FY2025, demonstrating consistent top-line expansion.
Analysts project 26.6% upside to a mean price target of $5.00, reflecting positive market sentiment.
The company maintains a low leverage band with a debt-to-equity ratio of 0.68, indicating conservative capital structure.
Liquidity risk is assessed as low, supported by a current ratio of 2.44, ensuring short-term solvency.
Operating income deteriorated to -$3.4 million in FY2025, widening losses despite revenue growth and indicating poor cost control.
Free cash flow turned negative to -$2.9 million in FY2025, reversing the positive generation seen in FY2024.
The company faces high dilution risk, which threatens existing shareholder value and equity ownership percentages.
In focus — financials by report
Revenue $13.9M; Operating income -$3.0M.
- ▍Revenue $13.9M
- ▍Operating income -$3.0M
- ▍Net margin 12.6%
Revenue $36.5M; Operating income -$1.6M.
- ▍Revenue $36.5M
- ▍Operating income -$1.6M
- ▍Net margin -4.1%
Revenue $23.6M; Operating income -$617.5k.
- ▍Revenue $23.6M
- ▍Operating income -$617.5k
- ▍Net margin -2.2%
Revenue $49.9M; Operating income -$3.4M.
- ▍Revenue $49.9M
- ▍Operating income -$3.4M
- ▍Net margin -6.5%
Revenue $43.3M; Operating income -$2.2M.
- ▍Revenue $43.3M
- ▍Operating income -$2.2M
- ▍Net margin -4.2%
Revenue $43.3M; Operating income -$2.2M.
- ▍Revenue $43.3M
- ▍Operating income -$2.2M
- ▍Net margin -4.2%
Revenue $34.2M; Operating income -$10.7M.
- ▍Revenue $34.2M
- ▍Operating income -$10.7M
- ▍Net margin -29.7%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,22 |
| Revenue | —no estimate | —no estimate | 110,6M USD |
| Operating income | —no estimate | —no estimate | -305,330 USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Diluted share count is materially above the basic share count.
- Source documents mention dilution or offering risk.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Chief Financial Officer · Option (right to buy) → Laird Superfood, Inc. Common StockDisposed 10 125 @ $0,81exercise · 2026-07-17
- Chief Financial Officer · Option (right to buy) → Laird Superfood, Inc. Common StockDisposed 29 988 @ $1,53exercise · 2026-07-17
- Chief Financial Officer · Option (right to buy) → Laird Superfood, Inc. Common StockDisposed 65 264 @ $3,17exercise · 2026-07-17
- Chief Financial Officer · Option (right to buy) → Laird Superfood, Inc. Common StockDisposed 9 855 @ $0,73exercise · 2026-07-17
- Chief Sales Officer · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 50 000 @ $9,00grant · 2026-07-09
- Chief Sales Officer · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 450 000 @ $4,36grant · 2026-07-09
- Chief Sales Officer · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 100 000 @ $6,00grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 60 000 @ $4,36grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 25 000 @ $6,00grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 60 000 @ $4,36grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 25 000 @ $9,00grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 60 000 @ $4,36grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 35 000 @ $9,00grant · 2026-07-09
- Director, Chief Innovator · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 60 000 @ $4,36grant · 2026-07-09
- Director, Chief Innovator · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 25 000 @ $6,00grant · 2026-07-09
- Director, Chief Innovator · Option (right to buy) → Laird Superfood, INC, Common StockAcquired 25 000 @ $9,00grant · 2026-07-09
- Chief Marketing Officer · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 450 000 @ $4,36grant · 2026-07-09
- Chief Marketing Officer · Option (right to buy) → Laird Superfood, Inc.Acquired 100 000 @ $6,00grant · 2026-07-09
- Chief Marketing Officer · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 50 000 @ $9,00grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 25 000 @ $6,00grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 85 000 @ $4,36grant · 2026-07-09
- Director · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 25 000 @ $6,00grant · 2026-07-09
- Director, Chief Executive Officer · Options (right to buy) → Laird Superfood, Inc. Common StockAcquired 450 000 @ $9,00grant · 2026-07-09
- Director, Chief Executive Officer · Option (right to buy) → Laird Superfood, Inc, Common StockAcquired 1 025 000 @ $4,36grant · 2026-07-09
- Director, Chief Executive Officer · Option (right to buy) → Laird Superfood, Inc. Common StockAcquired 500 000 @ $6,00grant · 2026-07-09
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Laird Superfood, Inc. company facts · 2026-05-28
- Laird Superfood, Inc. 10-Q 2026-05-14 · 2026-05-28
- Laird Superfood, Inc. 10-K 2026-03-30 · 2026-05-28
- Laird Superfood, Inc. 10-Q 2025-11-10 · 2026-05-28
- Laird Superfood, Inc. 10-Q 2025-08-07 · 2026-05-28
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
Insider activity
- Chief Financial Officer · Common StockOther 66 188 · 2026-07-17
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Revenue (YoY) (2025-12-31 vs 2024-12-31): 15.2%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -13.1%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -72.2%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 208.6%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -38.8%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 21.0%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -57.1%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -78.7%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 6.9%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -0.2%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 27.9%Derived (calculated)
- Net margin (FY 2025-12-31): -6.5%Derived (calculated)
- Gross margin (FY 2025-12-31): 37.9%Derived (calculated)
- Return on equity (FY 2025-12-31): -28.4%Derived (calculated)
- Return on assets (FY 2025-12-31): -16.9%Derived (calculated)
- Current ratio (FY 2025-12-31): 2.44xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.68xDerived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 188.9%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -421.8%Derived (calculated)
- Total assets (annual): USD 19.22MSEC XBRL filing
- Total liabilities (annual): USD 7.76MSEC XBRL filing
- R&D expense (annual): USD 329.81KSEC XBRL filing
- Pre-tax income (annual): USD -3.23MSEC XBRL filing
- Current assets (annual): USD 18.84MSEC XBRL filing